165 related articles for article (PubMed ID: 31663460)
1. Two-Way Clinical Messaging in a CML Specialty Pharmacy Service Model.
Sawicki C; Friend KE; Patel R; Polinski JM; Singh S
J Manag Care Spec Pharm; 2019 Nov; 25(11):1290-1296. PubMed ID: 31663460
[TBL] [Abstract][Full Text] [Related]
2. Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency.
Latremouille-Viau D; Guerin A; Gagnon-Sanschagrin P; Dea K; Cohen BG; Joseph GJ
J Manag Care Spec Pharm; 2017 Feb; 23(2):214-224. PubMed ID: 28125373
[TBL] [Abstract][Full Text] [Related]
3. Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population.
Paolella D; Cherry E; Jolly JA; DeClercq J; Choi L; Zuckerman A
J Manag Care Spec Pharm; 2019 Nov; 25(11):1282-1288. PubMed ID: 31663457
[TBL] [Abstract][Full Text] [Related]
4. Impact of a text messaging pilot program on patient medication adherence.
Foreman KF; Stockl KM; Le LB; Fisk E; Shah SM; Lew HC; Solow BK; Curtis BS
Clin Ther; 2012 May; 34(5):1084-91. PubMed ID: 22554973
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine Kinase Inhibitors and the Relationship With Adherence, Costs, and Health Care Utilization in Commercially Insured Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study.
Phuar HL; Begley CE; Chan W; Krause TM
Am J Clin Oncol; 2020 Jul; 43(7):517-525. PubMed ID: 32304434
[TBL] [Abstract][Full Text] [Related]
6. Change in Proportion of Days Covered for Statins Following Implementation of a Pharmacy Student Adherence Outreach Program.
Tamargo C; Sando K; Prados Y; Cowart K
J Manag Care Spec Pharm; 2019 May; 25(5):588-592. PubMed ID: 31039060
[TBL] [Abstract][Full Text] [Related]
7. Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia.
Darkow T; Henk HJ; Thomas SK; Feng W; Baladi JF; Goldberg GA; Hatfield A; Cortes J
Pharmacoeconomics; 2007; 25(6):481-96. PubMed ID: 17523753
[TBL] [Abstract][Full Text] [Related]
8. Effect of a Smart Pill Bottle and Pharmacist Intervention on Medication Adherence in Patients with Multiple Myeloma New to Lenalidomide Therapy.
Mauro J; Mathews KB; Sredzinski ES
J Manag Care Spec Pharm; 2019 Nov; 25(11):1244-1254. PubMed ID: 31663462
[TBL] [Abstract][Full Text] [Related]
9. Impact of Social Determinants of Health and Demographics on Refill Requests by Medicare Patients Using a Conversational Artificial Intelligence Text Messaging Solution: Cross-Sectional Study.
Brar Prayaga R; Agrawal R; Nguyen B; Jeong EW; Noble HK; Paster A; Prayaga RS
JMIR Mhealth Uhealth; 2019 Nov; 7(11):e15771. PubMed ID: 31738170
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine Kinase Inhibitors Initiation, Cost Sharing, and Health Care Utilization in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study.
Phuar HL; Begley CE; Chan W; Krause TM
J Manag Care Spec Pharm; 2019 Oct; 25(10):1140-1150. PubMed ID: 31556823
[TBL] [Abstract][Full Text] [Related]
11. Association between regular molecular monitoring and tyrosine kinase inhibitor therapy adherence in chronic myelogenous leukemia in the chronic phase.
Guérin A; Chen L; Dea K; Wu EQ; Goldberg SL
Curr Med Res Opin; 2014 Jul; 30(7):1345-52. PubMed ID: 24640967
[TBL] [Abstract][Full Text] [Related]
12. One-Year Outcomes of an Integrated Multiple Sclerosis Disease Management Program.
Groeneweg M; Forrester SH; Arnold B; Palazzo L; Zhu W; Yoon P; Scearce T
J Manag Care Spec Pharm; 2018 May; 24(5):458-463. PubMed ID: 29694287
[TBL] [Abstract][Full Text] [Related]
13. Adherence, Persistence, and Expenditures for High-Cost Anti-Inflammatory Drugs in Rheumatoid Arthritis: An Exploratory Study.
Khilfeh I; Guyette E; Watkins J; Danielson D; Gross D; Yeung K
J Manag Care Spec Pharm; 2019 Apr; 25(4):461-467. PubMed ID: 30917076
[TBL] [Abstract][Full Text] [Related]
14. Medication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO.
Haque R; Shi J; Chung J; Xu X; Avila C; Campbell C; Ahmed SA; Chen L; Schottinger JE
J Am Pharm Assoc (2003); 2017; 57(3):303-310.e2. PubMed ID: 28259737
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.
Liu X; Lewis JJ; Zhang H; Lu W; Zhang S; Zheng G; Bai L; Li J; Li X; Chen H; Liu M; Chen R; Chi J; Lu J; Huan S; Cheng S; Wang L; Jiang S; Chin DP; Fielding KL
PLoS Med; 2015 Sep; 12(9):e1001876. PubMed ID: 26372470
[TBL] [Abstract][Full Text] [Related]
16. The impact of tailored text messages on health beliefs and medication adherence in adults with diabetes: A randomized pilot study.
Gatwood J; Balkrishnan R; Erickson SR; An LC; Piette JD; Farris KB
Res Social Adm Pharm; 2016; 12(1):130-140. PubMed ID: 25980582
[TBL] [Abstract][Full Text] [Related]
17. The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics.
Lester CA; Mott DA; Chui MA
J Manag Care Spec Pharm; 2016 Jul; 22(7):801-7. PubMed ID: 27348281
[TBL] [Abstract][Full Text] [Related]
18. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
[TBL] [Abstract][Full Text] [Related]
19. Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia.
Wu EQ; Guerin A; Yu AP; Bollu VK; Guo A; Griffin JD
Curr Med Res Opin; 2010 Dec; 26(12):2861-9. PubMed ID: 21062136
[TBL] [Abstract][Full Text] [Related]
20. The impact of a retail prescription synchronization program on medication adherence.
Girdish C; Shrank W; Freytag S; Chen D; Gebhard D; Bunton A; Choudhry N; Polinski J
J Am Pharm Assoc (2003); 2017; 57(5):579-584.e1. PubMed ID: 28764890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]